Clinical Trials
15 trialsNCT07102212 2026-05-18
FOCUS
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT03756792 2026-01-29
Assessing Patient Anxiety During Mohs Micrographic Surgery
Wake Forest University Health Sciences
Phase NA Completed
NCT04385732 2025-05-08
IMAGE
Melanoma and Skin Cancer Trials Limited
Phase NA Active not recruiting
NCT06767332 2025-01-09
FAME
Leiden University Medical Center
Phase NA Recruiting
NCT04565769 2024-12-06
Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
Aarhus University Hospital
Active not recruiting
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT04604158 2024-05-21
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center
Phase NA Completed
NCT00979693 2023-12-26
Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
Multidisciplinary Association for Psychedelic Studies
Phase 2 Withdrawn
NCT03174808 2019-11-27
Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)
Yale University
Phase NA Terminated
NCT03485937 2019-10-22
Impact of Videos on Patient Anxiety and Satisfaction
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT02352623 2016-05-26
Quality of Life and Surgical Late Effects of Melanoma Treatment
Herlev Hospital
Completed
NCT00014482 2013-06-18
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00578214 2012-02-09
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
Mayo Clinic
Phase NA Completed
NCT00956475 2011-08-24
Quality of Life in Younger Leukemia and Lymphoma Survivors
Case Comprehensive Cancer Center
Completed
NCT01316744 2011-05-13
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
National Cancer Institute (NCI)
Phase 3 Unknown